A century of barbiturates in neurology;Un siglo de barbitúricos en neurología

Revista de Neurologia

Volumn 39, Issue 8, 2004, Pages 767-775

  López Muñoz, Francisco ^a   Ucha Udabe, R ^b   Alamo Gonzalez C ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

Antiepileptic drugs; Barbiturates; Epilepsy; History of neurology; Hypnotics; Sleep disorders

Indexed keywords

AMOBARBITAL; ANTICONVULSIVE AGENT; BARBITAL; BARBITURIC ACID DERIVATIVE; BELLADONNA ALKALOID; BORATE SODIUM; BROMIDE; BUTETHAL; CALCIUM CHLORIDE; CARBAMAZEPINE; CHLORAL HYDRATE; GLUTETHIMIDE; GLYCEROPHOSPHATE; JACKSONAL; METHAQUALONE; METHYLPHENOBARBITAL; OPIATE; PARALDEHYDE; PENTOBARBITAL; PHENOBARBITAL; PRIMIDONE; SECOBARBITAL; SEDATIVE AGENT; THIOPENTAL; UREA DERIVATIVE; ZINC SULFATE;

DRUG FATALITY; DRUG OVERDOSE; DRUG SAFETY; EPILEPSY; HUMAN; NEUROLOGIC DISEASE; NEUROLOGY; REVIEW; SEDATION;

EID: 17644393585     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3908.2004428     Document Type: Review

References (60)

1. Álamo C, López-Muñoz F, Echániz T, Cuenca E. Fármacos ansiolíticos, sedantes e hipnóticos. In López-Muñoz, F, Álamo C, eds. Historia de la Neuropsicofarmacología. Una nueva aportación a la terapéutica farmacológica de los trastornos del Sistema Nervioso Central. Madrid: Eurobook/Servicio de Publicaciones de la Universidad de Alcalá; 1998. p. 245-68.
2. Hollister LE. The pre-benzodiazepine era. J Psychoactive Drugs 1983; 15: 9-13.
3. Scott DF. The discovery of antiepileptic drugs. J Hist Neurosci 1992; 1: 111-8.
4. Lehmann HE. Before they called it Psychopharmacology. Neuropsychopharmacology 1993; 8: 291-303.
5. Sneader W. Drug discovery: the evolution of modern medicines. Chichester: John Wiley & Sons; 1985.
6. Shorvon SD, Sander JWAS. Historical introduction. The treatment of epilepsy at the National Hospital; Queen Square, 1857-1939: a mirror of the first phase of the modern history of medical and surgical therapy. In Shorvon SD, Dreifuss F, Fish D, Thomas D, eds. The treatment of epilepsy. Oxford: Blackwell Science; 1996. p. XVII-XLIV.
7. Shorter E. A history of psychiatry. From the era of the asylum to the age of Prozac. New York: John Wiley & Sons; 1997.
8. Griesinger W. Die Pathologie und Therapie der psychischen Krankheiten. Stuttgart: Krabbe; 1867.
9. Woodward SB. Observations on the medical treatment of insanity (1846). Am J Psychiatry 1994; 151 (Suppl 6): 220-30.
10. Norton A. Depression. Br Med J 1979; 2: 429-30.
11. Liebreich O. Das Chloralhydrat ein neues Hypnoticum und Anästheticum, und dessen Anwendung in die Medizin. Eine Arzneimittel-Unterssuchung. Berlin: Muller; 1869.
12. Sourkes TL. Early clinical neurochemistry of CNS-active drugs. Chloral hydrate. Mol Chem Neuropathol 1992; 17: 21-30.
13. Locock C. Discussion of paper by E.H. Sieveking. Analysis of 52 cases of epilepsy observed by author. Lancet 1857; i: 527.
14. Balme R. Early medicinal uses of bromides. J Royal Coll Physic Lond 1976; 10: 205-8.
15. Cervello V. Sull'azione fisiologica della paraldeide e contributio allo studio del cloralio idrato. Ricerche. Arch Sc Med (Torino) 1882; 6: 177-214.
16. Von Baeyer A. Untersuchungen Über die Harnsauregruppe. Annalen 1864; 130: 129.
17. Grimaux E. Synthèse des dérivés uriques de la série de l'alloxane. Bull Soc Chim Fr 1879; 31: 146.
18. Carter MK. The history of barbituric acid. J Chem Educ 1951; 28: 525-8.
19. Dundee JW, McIlroy PDA. The history of the barbiturates. Anaesthesia 1982; 37: 726-34.
20. Cohen WAT. Chemisch-Historische Aanteekeningen. De nomenclatuur van enkele organische zuren. Chemisch Weekblad 1943; 40: 176.
21. Sharpless SK. The barbiturates. In Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics. 4 ed. New York: MacMillan; 1970. p. 98-120.
22. Fieser LF. Organic chemistry. Boston: DC Heath; 1944. p. 247.
23. Conrad M, Guthzeit M. Über Barbitur-saure. Berichte 1881; 14: 1943.
24. Fischer E, Von Mering J. Ueber ein neue Klasse von Schlafmitteln. Therapie Gegenwart 1903; 44: 97-101.
25. Lehmann HE, Ban TA. Pharmacotherapy of tension and anxiety. Springfield, IL: Charles C. Thomas; 1970.
26. Von Husen H. Über Veronal. PNW 1904; 6: 57-61.
27. Loewe S. Klinische Erfahrungen mit Luminal. Dtsch Med Wchnschr 1912; 38: 947-8.
28. Juliusburger O. Ueber Luminal ein neues Hypnoticum und Sedativum. Berl Klin Wchnschr 1912; 49: 940-2.
29. Impens E. Pharmakologisches über Luminal, oder Phenylethil barbiturat saure, ein neues Hypnoticum. Dtsch Med Wchnschr 1912; 38: 945-7.
30. Shonle HA, Moment A. Some new hypnotics of the barbituric acid series. J Am Chem Soc 1923; 45: 243-9.
31. Volwiler EH, Tabern DL. 5,5-substituted barbituric acid. J Am Chem Soc 1930; 52: 393-407.
32. Tabern DL, Volwiler EH. Sulfur-contained barbiturate hypnotics. J Am Chem Soc 1935; 57: 1961-3.
33. Hauptmann A. Luminal bei Epilepsie. MMW Munch Med Wochenschr 1912; 59: 1907.
34. Brooks C. Report of the Medical Officer. The National Society for Epileptics. Thirtieth Annual Report, 19; 1922.
35. Brooks C. Report of the Medical Officer. The National Society for Epileptics. Thirty-first Annual Report, 23; 1923.
36. Haward FC. Report of the Medical Officer. The National Society for Epileptics. Thirty-fifth Annual Report 1928; 24.
37. Iváñez V, Díez-Tejedor E. Fármacos antiepilépticos y anticonvulsionantes: aspectos históricos. In López-Muñoz, F, Álamo C, eds. Historia de la Neuropsicofarmacología. Una nueva aportación a la terapéutica farmacológica de los trastornos del sistema nervioso central. Madrid: Eurobook/Servicio de Publicaciones Universidad de Alcalá; 1998. p. 347-64.
38. Shorvon SD. Handbook of epilepsy treatment. Oxford: Blackwell Science; 2000.
39. Weese H. Pharmakologie des Prominal. Dtsch Med Wchnschr 1932; 58: 696.
40. Handley R, Stewart ASR. Mysoline: a new drug in the treatment of epilepsy. Lancet 1952; 262: 742.
41. Bogue JY, Carrington HC. The evaluation of Mysoline -a new anticonvulsant drug. Br J Pharmacol 1953; 8: 230-5.
42. Butler TC, Waddell WJ. Metabolic conversion of primidone (Mysoline) to phenobarbital. Proc Soc Exp Biol N Y 1956; 93: 544-66.
43. Oleson OV, Dam M. The metabolic conversion of primidone to phenobarbitone in patients under long-term treatment. Acta Neurol Scand 1967; 43: 348-56.
44. Merrit HH, Putnam TJ. Sodium diphenylhydantoinate in treatment of convulsive disorders. JAMA 1938; 111: 1068-73.
45. Koller WC, Hristova A, Brin M. Pharmacological treatment of essential tremor. Neurology 2000; 54 (11 Suppl 4): 30-8.
46. Johns MW. Self-poisoning with barbiturits in England an Wales during 1959-74. Br Med J 1977; i: 1128-30.
47. Escohotado A. Historia elemental de las drogas. Barcelona: Anagrama; 1996.
48. Glatt MM. The abuse of barbiturates in the United Kingdom. UNODC Bulletin on Narcotics 1962; 2: 19-38.
49. Richards R. Symptoms of poisoning by hypnotics of barbituric acid groups. Br Med J 1934; i: 331.
50. Barraclough BM. Are there safer hypnotics than barbiturates. Lancet 1974; i: 57-8.
51. Plant M. What aetiologies? In Edwards G, Busch C, eds. Drug problems in Britain. A review of ten years. London: Academic Press; 1981. p. 245-80.
52. Caldwell AE. History of psychopharmacology. In Clark WG, Del Giudice J, eds. Principles of psychopharmacology. New York: Academic Press; 1970. p. 9-30.
53. Jacobsen E. The early history of psychotherapeutic drugs. Psychopharmacology 1986; 89: 138-44.
54. Ayd FJ. The early history of modern psychopharmacology. Neuropsychopharmacology 1991; 5: 71-84.
55. Frankenburg FR. History of the development of antipsychotic medication. Psychiatr Clin North Am 1994; 17: 531-40.
56. López-Muñoz F, Alamo C, Cuenca E. La 'década de oro' de la psicofarmacología (1950-1960): trascendencia histórica de la introducción clínica de los psicofármacos clásicos. Psiquiatria.com 2000; 4 [online]. URL: http://www.psiquiatria.com/psiquiatria/ revista/47/1800/ ?++interactivo. Fecha último acceso: 07.01.2001.
57. Ban TA. Pharmacotherapy of mental illness. A historical analysis. Prog Neuro-Psychopharmacol Biol Psychiatr 2001; 25: 709-27.
58. Healy D. The creation of psychopharmacology. Cambridge: Harvard University Press; 2002.
59. López-Muñoz F, Álamo C, Rubio G, Cuenca E. Half a century since the clinical introduction of chlorpromazine and the birth of modern psychopharmacology. Prog Neuro-Psychopharmacol Biol Psychiat 2004; 28: 205-8.
60. Charney DS, Mihic SJ, Harris RA. Hypnotics and sedatives. In Hardman JG, Limbird LE, eds. Goodman & Gilman's. The pharmacological basis of therapeutics. 10 ed. New York: McGraw-Hill; 2001. p. 399-427.